St. Lukes University Health Network

Bethlehem, Pennsylvania 18102

16 studies enrolling now · 72 studies all time

What they study most

Abdominal Aortic Aneurysm, Acute Kidney Injury, Acute T Cell Leukemia Lymphoma, Adolescent Idiopathic Scoliosis, Advanced BRAFV600 Wild-type Melanoma, Advanced Breast Cancer, Advanced Cutaneous Melanoma, Advanced Ovarian Cancer, Advanced Ovarian Carcinoma, Ankle Fractures, Ankle Injuries and Disorders, Approved Alternative Therapy

Studies at this site

• A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer — Recruiting now
• A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA) — Recruiting now
• A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With HR+, HER2- Advanced Breast Cancer — Recruiting now
• INHANCE Stemless Reverse Shoulder IDE — Recruiting now
• Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01) — Recruiting now
• Advanced SPinal Innovations With Robotics and Enabling Technology Registry — Recruiting now
• Data Collection of New Spectral CT Imaging Method — Recruiting now
• A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM) — Recruiting now
• DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) — Recruiting now
• Nectero EAST System Clinical Study — Recruiting now
• Antibiotic Cement Bead Pouch Versus Negative Pressure Wound Therapy — Recruiting now
• Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial — Recruiting now
• A Study to Evaluate Efficacy and Safety of Light Dose in Subjects With PWB Treated With Hemoporfin PDT — Recruiting now
• HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial — Recruiting now
• Non-Contact Low-Frequency Ultrasound Vs Standard LaLonde Protocol for Fingertip Injury Wound Healing — Recruiting now
• myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home — Recruiting now
• Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer — Running, not enrolling
• A Study to Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC) — Running, not enrolling
• A Study Comparing Navlimetostat (BMS-986504) in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30) — Running, not enrolling
• Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection — Completed
• A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS) — Running, not enrolling
• Exparel Use in Peripheral Nerve Blocks and Local Infiltration for Foot and Ankle Surgery — Completed
• Women's Heart Attack Research Program: Stress Ancillary Study — Completed
• 9-ING-41 in Patients With Advanced Cancers — Running, not enrolling
• A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer — Running, not enrolling
• Heart Attack Research Program- Imaging Study — Running, not enrolling
• Personalized Therapy Study - Attain Stability Quad Post-Approval Study — Running, not enrolling
• Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy. — Running, not enrolling
• NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 Therapy — Running, not enrolling
• Personalized Therapy Study - HFRS (TriageHF) Post Approval Study — Running, not enrolling
• Personalized Therapy Study - Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS) — Running, not enrolling
• CemiplimAb Survivorship Epidemiology — Completed
• A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101) — Completed
• A Study of Atezolizumab Plus Cobimetinib and Vemurafenib Versus Placebo Plus Cobimetinib and Vemurafenib in Previously Untreated BRAFv600 Mutation-Positive Patients With Metastatic or Unresectable Locally Advanced Melanoma — Completed
• Standard Chemotherapy vs. Chemotherapy Guided by Cancer Stem Cell Test in Recurrent Glioblastoma — Completed
• NOVOCART®3D for Treatment of Articular Cartilage of the Knee — Running, not enrolling
• ThRombosis ExclUsion STudy — Stopped early
• The Efficacy of Liposomal Bupivacaine in Ultrasound Guided Supraclavicular Nerve Blocks for Hand and Wrist Surgery — Running, not enrolling
• ITIL-168 in Advanced Melanoma — Stopped early
• Exploring Safety & Clinical Benefit of Anti-Influenza Immunoglobulin Intravenous in Hospitalized Adults With Influenza A — Completed
• A Phase II Study of Single Agent MEK162 in Patients With Advanced Melanoma — Completed
• Safety and Efficacy Study of the Evoke™ SCS System With Feedback vs. Conventional Stimulation — Completed
• Left Atrial Posterior Wall and PV Isolation Using Cryoballoon for Treatment of Persistent AF — Status unconfirmed
• Study to Assess Safety and Efficacy of the Second Mitochondrial-derived Activator of Caspases (SMAC) Mimetic Debio 1143 — Completed
• Chronic Hypertension and Pregnancy (CHAP) Project — Completed
• Trial of pIL-12 Electroporation Malignant Melanoma — Completed
• Tavo and Pembrolizumab in Patients With Stage III/IV Melanoma Progressing on Either Pembrolizumab or Nivolumab Treatment — Status unconfirmed
• An International Pulmonary Embolism Registry Using EKOS — Completed
• A Study of VB-111 With Paclitaxel vs Paclitaxel for Treatment of Recurrent Platinum-Resistant Ovarian Cancer (OVAL) — Completed
• A Study to Assess PV-10 Chemoablation of Cancer of the Liver — Status unconfirmed